The case study discusses S R K Pharma Ltd. and CEO Mr. Ganguly's concerns about competition in the pharmaceutical industry, leading to a decision to diversify by introducing new plant-extract-based medicines. Implementation was delayed due to a lack of skilled employees, with plans for training and hiring now set for October 2007. The author criticizes this delay and suggests outsourcing production to expedite the process and mitigate risks.

1. Organization and Management
case study
By,
Kishan k shenoy
4NM15MBA73
I MBA (Section B)

2.  Mr. Ganguly is the CEO of S R K Pharma Ltd.
 On 12th December 2005 core committee meeting was held
 The CEO S R K Ltd Mr.Gangly the Marketing manager Finance manager and
Production manager were attend the meeting
 In the meeting Mr. Ganguly expressed his fear of view regarding the competition
in pharmaceutical industry and the company’s market share in the next decade
 The members of core group committee has disused this problem for several days
 At last they came up with strategy of diversification of there business to compete
in market against there competitor
 So they made strategy of introducing new medicine which is made out of extraction
of plant which will add to there companies line of production mix
Introduction to Case

3. 
 On February 2006 the company had made arrangement regarding to implementing
strategy of production and marketing medicine based on plant extraction
 Company plan was to start its commercial production on August 2006
 The CEO of S R K ltd Mr Ganguly found that the employees of the company were lack
in required skill available for the extraction of plant to produce medicine.
 Hence company forced to delay there introduction of new strategy to Market and
commercial production till October 2007
 To train there existing employees and appointment of new employees
CONT…

4. 
 According to me its correct decision because of introduction of new
product mix in company it will help to compete in market
 Because companies diversification strategy that is production of
medicine from extract of plant this strategy will help the company to
stable its market share in next decade
1. How far Mr. Ganguly correct in deciding on introducing a new
plant extract based medicine in company’s product mix?

5. 
 Production of medicine with help of extraction of plant
 Arrangements has made to implement the strategy with respect to
production and marketing
 The core group members came up with strategy of diversification of
business
 With introduction of new product mix after long deliberation and
discussion
2. What exactly the business strategy introduced by the core group
after days long deliberations and discussions?

6. 
 The company mainly failed deciding exact date of starting
commercial production because
 Lack of required skill was found in the employee of S R K Ltd to
prepare medicine out of extract of plant
 To train the existing employees and appointment new skilled
employees
3. Why the company core group failed in deciding on the exact
date of starting the commercial production?

7. 
 If I was in position of Mr Gangly I would have preferred to know
how company can face competition and tackle situation with
improvement in promotion of product and development of existing
medicine
 I like to suggest that if i would have preferred to introduce new
strategy i would have outsourced the work for the skilled employees
who knows how to produce medicine from extract of plant rather than
training existing employees. Because its time consuming process we
must meet the competition so we cant delay the process.
 By outsourcing the work we will also share our risk along with profit
which is one of good decision to meet competition in current situation
4.If, you were in Ganguly’s position, what would have been your
strategy in deciding on the members of the core group and starting
the commercial production?

8. 
THANK YOU